Synthesis and antitubercular evaluation of aryl substituted 2-oxazolines from L-amino acids

Authors

  • Leidiane Araujo de Souza Fiocruz-Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos-Farmanguinhos. Rua Sizenando Nabuco, 100, Manguinhos, 21041-250 - Rio de Janeiro-RJ.
  • Emerson Teixeira da Silva Fiocruz-Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos-Farmanguinhos. Rua Sizenando Nabuco, 100, Manguinhos, 21041-250 - Rio de Janeiro-RJ.
  • Maria Cristina Silva Lourenço Instituto de Pesquisas Clínica Evandro Chagas – IPEC – Av. Brasil, 4365 - Manguinhos Rio de Janeiro – RJ
  • Marcus Vini­cius Nora de Souza Fiocruz-Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos-Farmanguinhos. Rua Sizenando Nabuco, 100, Manguinhos, 21041-250 - Rio de Janeiro-RJ.

DOI:

https://doi.org/10.13171/mjc.2.5.2014.06.01.23

Abstract

This paper describes the synthesis and the in vitro antibacterial activity of a series of twelve substituted aryl-2-oxazolines against Mycobacterium tuberculosis. Seven compounds showed activity and two compounds exhibited a minimal inhibitory concentration (MIC) of 25 ï­g/mL were not cytotoxic for the host cells in cell viability assay. These results could be a good starting point for the development of new antitubercular lead series based on this family of compounds.

References

- (a) E. Rossegger, V. Schenk, F. Wiesbrock, Polymers [Elektronische Ressource] 2013, 5, S. 956-1011. (b) A. Kelly, A. Hecke, B. Wirnsberger, C. Wapll., F. Wiesbrock, Polymer Preprints 2012, 53(1), S. 362 – 363.

- (a) C. Chaimbault, J.J. Bosc, C. Jarry, C. Pharm. and Pharmacol. Commun. 1999, 5, 211-215. (b) H. Suga, H. Fujieda, Y. Hirotsu, T. Ibata, J. Org. Chem. 1994, 59, 3359-3364.

- (a) K. Kempe, M. Lobert, R. Hoogenboom, U. S. Schubert, J. Comb. Chem. 2009, 11, 274-280. (b) S. Crosignani, D. Swinnen, J. Comb. Chem. 2005, 7, 688-696.

- (a) W. C. Wong, D. Wang, C. Forray, P. J-J. Vaysse, T. A. Branchek, C. A. Gluchowski, Bioorg. Med. Chem. Lett. 1994, 4, 2317-2322. (b) J. J. Bosc, C. Jarry, A. Carpy, E. Panconi, P. Descas, Eur. J. Med. Chem. 1992, 27, 437-442. (c) L. Fan, E. Lobkovsky,

- B. Ganem, Org. Lett. 2007, 9, 2015-2017.

- (a) G. C. Moraski, L. D. Markley, M. Chang, S. Cho, S. G. Franzblau, C. H. Hwang,

- H. Boshoff, M. J. Miller, Bioorg. Med. Chem. 2012, 20, 2214–2220. (b) A. P. Khadke, A. M. Patil, B. B. Jain, Int. J. Pharm. Biol. Sci. 2011, 1, 501-509. G. C. Moraski, M. Chang, A. Villegas-Estrada, S.G. Franzblau, U. Mollmann, M. J. Miller, Eur. J. Med. Chem., 2010, 45, 1703–1716. (c) S. H. Cardoso, M. V. de Almeida, J. V. de Assis, R. Diniza, N. L. Speziali, M. V. N. de Souza, J. Sulfur Chem. 2008, 29, 145–149

- M. V. N. de Souza, Mycobacterial Diseases, 2012, 2, 1-1.

- http://www.who.int/tb/challenges/xdr/xdrconsultation/en/index.html, accessed at march of 2013

- (a) A. S. Prasad, B. Satyanarayana, Pharma Chem. 2012, 4, 93-99. (b) M.-F. Pouliot, L. Angers, J.-D. Hamel, J.-F. Paquin, Tetrahedron Lett. 2012, 53, 4121-4123. (c) M. Mamaghani, N. O. Mahmoodi, S. F. Ghasemi, J. Iranian Chem. Soc. 2010, 7, 972-977.

(d) A. R. Katritzky, C. Cai, K. Suzuki, S. K. Singh, J. Org. Chem., 2004, 69, 811-814. (e) I. Mohammadpoor-Baltork, M. Moghadam, S. Tangestaninejad, V. Mirkhani, S.F. Hojati, Polyhedron, 2008, 27, 750-758.

- (a) R. S. B. Gonçalves, A. C. Pinheiro, E. T. da Silva, J. C. S. da Costa, C. R. Kaiser, M. V. N. de Souza, Synth. Commun. 2011, 41, 1276-1281. (b) A. I. Vogel in Vogel’s: Textbook of The Practical Organic Chemistry, Longman Scientific Technical, Fifth Edition, 1989, pp 602-603.

- R. M. Denton, J. An, B. Adeniran, A. J. Blake, W. Lewis, A.M. Poulton, A.M., J. Org. Chem., 2011, 76, 6749-6767.

- S.-Y. Tosaki, R. Tsuji, T. Ohshima, M. Shibasaki, J. Am. Chem. Soc., 2005, 127, 2147-2155. D-M. Gou, Y.-C. Liu, C.-S. Chen J. Org. Chem., 1993, 58, 1287-1289 and references cited.

- M. Mroczkiewicz R. Ostaszewski, Tetrahedron, 2009, 65, 4025-4034.

- R. N. Boyd, R.C. Rittner, J. Am. Chem. Soc., 1960, 82, 2032-2034.

- F. Menges, M. Neuburger, A. Pfaltz, Org. Lett., 2002, 4, 4713–4716.

- R.N. Constantine, N. Kim, R. C. Bunt, Org. Lett., 2003, 5, 2279-2282.

- A.R. Battersby, R.S. Kapil, Tetrahedron Lett., 1965, 39, 3529-3531

- M. Mamaghani, N.O. Mahmoodi, S. F. Ghasemi, J. Iran. Chem. Soc., 2010, 7, 972-977.

- B.S. Bodnar, P.F. Vogt, J. Org. Chem., 2009, 74, 2598-2600.

- V. Werf, A. Calvin, J. Am. Chem. Soc., 1954, 76, 1231-1235.

- S. Kumar, K. Kandasamy, H. B. Singh, R. J. Butcher, New J. Chem., 2004, 28, 640-645.

- T. Ohshima, T. Iwasaki, K. Mashima, Chem. Commun., 2006, 2711-2713.

- H. Jiang, S. Yuan, W. Wan, K. Yang, H. Deng, J. Hao, Eur. J. Org. Chem., 2010, 4227–4236.

- M. C. Pirrung, L. N. Tumey, J. Comb. Chem., 2005, 2, 675-680.

- J. Suzuki, T. Ishida, K. Toda, T. Ikeda, Y. Isukidate, Y. Kikuchi, Eur. Pat. Appl. (1989), EP 345775 A1 19891213.

- H. Jiang, W. Lu, Y. Cai, W. Wan, S. Wu, S. Zhu, J. Hao, Tetrahedron, 2013, 69, 2150-2156.

- S. G. Franzblau, R. S. Witzig, J. C.McLaughlin, P. Torres, G.Madico, A. Hernandez, M.T.Degnan, M. B. Cook, V. K. Quenzer, R. M. Ferguson, and R. H. Gilman, J. Clin. Microbiol., 1998, 36, 362–366.

- J. D. Vanitha, C. N. Paramasivan, Mycobacteriology, 2004, 49, 179–182 .

- M. C. Souza, A. C. Siani, M. F. S. Ramos, O. M. Limas, M. G. M. O. Henrique, Pharm., 2003, 8, 582–586.

Downloads

Published

2014-01-06

Issue

Section

Medicinal Chemistry